 Penumbra Inc NYSE: PEN reported Q1 sales that beat Street expectations, driven by Vascular upside, and reiterated its 2022 revenue guidance. Wells Fargo lowered the price target to 265 from 321, which is equivalent to a 52.2 upside. 